Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Sales | 8,730 | 0 | 11,900 | 14,680 | 10,020 |
| Cost of Goods | 1,950 | N/A | 3,660 | 5,890 | 4,040 |
| Gross Profit | 6,780 | 6,450 | 8,230 | 8,780 | 5,970 |
| Operating Expenses | 21,150 | 14,050 | 32,040 | 32,580 | 22,560 |
| Operating Income | -13,420 | -14,050 | -23,140 | -22,900 | -16,540 |
| Other Income | -10 | 0 | 950 | 2,280 | 3,250 |
| Pre-tax Income | -13,430 | -14,050 | -22,190 | -20,620 | -13,290 |
| Income Tax | 9 | N/A | 4 | 1 | 1 |
| Net Income Continuous | -10,891 | -15,848 | -23,691 | -19,097 | -13,399 |
| Net Income | $-13,440 | $-15,848 | $-22,200 | $-20,630 | $-13,290 |
| EPS Basic Total Ops | -530.00 | -780.00 | -1,000.00 | -160.00 | -130.00 |
| EPS Basic Continuous Ops | -531.27 | -780.69 | -999.62 | -161.16 | -124.87 |
| EPS Diluted Total Ops | -530.00 | -780.00 | -1,000.00 | -160.00 | -130.00 |
| EPS Diluted Continuous Ops | -531.27 | -780.69 | -999.62 | -161.16 | -124.87 |
| EBITDA(a) | $-13,250 | $-13,840 | $-22,830 | $-22,900 | $-16,540 |